Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3403315
Max Phase: Preclinical
Molecular Formula: C35H56N6O8
Molecular Weight: 688.87
Molecule Type: Small molecule
Associated Items:
ID: ALA3403315
Max Phase: Preclinical
Molecular Formula: C35H56N6O8
Molecular Weight: 688.87
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCN(CC)C(=O)[C@H](Cc1ccc(OC)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)COC(=O)[C@@H]1CCCN1C(C)=O)C(C)C
Standard InChI: InChI=1S/C35H56N6O8/c1-9-40(10-2)34(46)28(19-24-13-15-25(48-8)16-14-24)38-32(44)27(18-21(3)4)37-33(45)30(22(5)6)39-31(43)26(36)20-49-35(47)29-12-11-17-41(29)23(7)42/h13-16,21-22,26-30H,9-12,17-20,36H2,1-8H3,(H,37,45)(H,38,44)(H,39,43)/t26-,27-,28-,29-,30-/m0/s1
Standard InChI Key: RIONLOFNCHTAMF-IIZANFQQSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 688.87 | Molecular Weight (Monoisotopic): 688.4160 | AlogP: 1.14 | #Rotatable Bonds: 18 |
Polar Surface Area: 189.47 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 14 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 11.91 | CX Basic pKa: 7.22 | CX LogP: 0.94 | CX LogD: 0.72 |
Aromatic Rings: 1 | Heavy Atoms: 49 | QED Weighted: 0.16 | Np Likeness Score: -0.34 |
1. Zhen XL, Yin WH, Tian X, Ma ZJ, Fan SM, Han JR, Liu S.. (2015) Synthesis and biological evaluation of open-chain analogs of cyclic peptides as inhibitors of cellular Shp2 activity., 23 (10): [PMID:25865131] [10.1016/j.bmc.2015.03.035] |
Source(1):